Please sign in to follow a disease.

MAS

Clinical trials for MAS explained in plain language.

Never miss a new study

Get alerted when new MAS trials appear

Sign up with your email to follow new studies for MAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New drug aims to calm dangerous immune storms in Still's and lupus patients

Disease control Completed

This study tested a drug called emapalumab in 33 children and adults with macrophage activation syndrome (MAS), a life-threatening immune overreaction, linked to Still's disease or lupus. The goal was to see if the drug could safely control the condition and reduce the need for h…

Matched conditions: MAS

Phase 3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control

Last updated Aug 28, 2026 00:00 UTC

MAS

Get alerted when new MAS trials appear

New drug aims to calm dangerous immune storms in Still's and lupus patients